Published in Neuroradiology on September 28, 2010
"Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis? Neuroradiology (2014) 0.91
Posterior fossa tumors in children: developmental anatomy and diagnostic imaging. Childs Nerv Syst (2015) 0.82
Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review. Cancer Imaging (2013) 0.82
Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain Behav (2014) 0.82
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI. AJNR Am J Neuroradiol (2016) 0.77
Advanced MRI for Pediatric Brain Tumors with Emphasis on Clinical Benefits. Korean J Radiol (2017) 0.75
MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma. AJNR Am J Neuroradiol (2016) 0.75
Susceptibility Imaging in Glial Tumor Grading; Using 3 Tesla Magnetic Resonance (MR) System and 32 Channel Head Coil. Pol J Radiol (2017) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Angiogenic factors. Science (1987) 15.22
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology (2006) 4.06
Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol (2006) 3.68
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol (2007) 2.18
Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging (2009) 2.14
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol (2007) 1.84
Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol (2004) 1.82
High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed (2001) 1.70
Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging (2006) 1.70
Population-based epidemiologic data on brain tumors in German children. Cancer (2001) 1.58
Imaging of intracranial haemorrhage. Lancet Neurol (2008) 1.54
Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med (2008) 1.52
Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40
Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol (2007) 1.38
Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol (2007) 1.37
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol (2008) 1.33
Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg (1996) 1.31
Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg (1996) 1.25
Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage. Chin Med J (Engl) (2008) 1.23
Detection of intracranial hemorrhage with susceptibility-weighted MR sequences. AJNR Am J Neuroradiol (1999) 1.14
Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology (2003) 1.10
Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology (1997) 1.04
Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). Neuroimage (2008) 1.03
Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer (2006) 0.99
Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys (2006) 0.96
Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. Neuroradiology (1990) 0.91
MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions. J Magn Reson Imaging (1992) 0.90
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol (2010) 4.94
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol (2011) 3.56
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol (2009) 3.32
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell (2011) 2.87
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol (2011) 2.82
Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol (2005) 2.73
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol (2005) 2.34
Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke. Circ Res (2013) 2.21
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol (2005) 2.19
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol (2004) 2.16
R2* magnetic resonance imaging of the liver in patients with iron overload. Blood (2009) 2.05
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol (2010) 2.04
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol (2008) 1.87
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemother Pharmacol (2014) 1.78
High-grade astrocytoma in very young children. Pediatr Blood Cancer (2007) 1.77
ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res (2003) 1.71
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol (2007) 1.67
Phase I study of everolimus in pediatric patients with refractory solid tumors. J Clin Oncol (2007) 1.61
Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med (2008) 1.52
Variability in PET quantitation within a multicenter consortium. Med Phys (2010) 1.46
Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol (2005) 1.39
Alexander disease: An important mimicker of focal brainstem glioma. Pediatr Blood Cancer (2009) 1.39
Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med (2005) 1.39
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol (2011) 1.39
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed (2011) 1.39
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol (2006) 1.38
Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type. BMC Genomics (2014) 1.34
Diffusion tensor imaging: the normal evolution of ADC, RA, FA, and eigenvalues studied in multiple anatomical regions of the brain. Neuroradiology (2009) 1.33
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol (2008) 1.33
Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor Consortium. J Biopharm Stat (2009) 1.29
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol (2010) 1.27
The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol (2005) 1.26
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol (2012) 1.25
Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J Biol Chem (2008) 1.24
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Association, commissural, and projection pathways and their functional deficit reported in literature. J Comput Assist Tomogr (2006) 1.19
Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst (2013) 1.17
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. J Clin Oncol (2012) 1.17
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol (2012) 1.16
Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma. J Clin Oncol (2012) 1.16
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol (2008) 1.15
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med (2011) 1.14
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol (2011) 1.11
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol (2014) 1.10
Preclinical models for neuroblastoma: establishing a baseline for treatment. PLoS One (2011) 1.09
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer (2010) 1.09
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol (2011) 1.07
Pseudo-reorganization of language cortical function at fMR imaging: a consequence of tumor-induced neurovascular uncoupling. AJNR Am J Neuroradiol (2003) 1.07
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol (2011) 1.05
Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol (2007) 1.05
Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol (2008) 1.05
Real-time catheter tracking and adaptive imaging. J Magn Reson Imaging (2003) 1.05
Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload. Pediatr Radiol (2010) 1.05
ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J Magn Reson Imaging (2009) 1.04
White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumor. Neuro Oncol (2012) 1.04
MR-guided endovascular interventions: device visualization, tracking, navigation, clinical applications, and safety aspects. Magn Reson Imaging Clin N Am (2005) 1.03
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Clin Cancer Res (2009) 1.02
Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI. J Magn Reson Imaging (2003) 1.02
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol (2004) 1.02
Coronal computed tomography analysis of frontal cells. Am J Rhinol (2003) 1.00
Improved renal perfusion measurement with a dual navigator-gated Q2TIPS fair technique. Magn Reson Med (2010) 0.99
Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer (2006) 0.99
Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia. Pediatr Blood Cancer (2011) 0.96
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging (2012) 0.96
Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol (2008) 0.96
Evaluation of respiratory liver and kidney movements for MRI navigator gating. J Magn Reson Imaging (2011) 0.95
Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys (2011) 0.95
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res (2008) 0.94
Irradiation of pediatric high-grade spinal cord tumors. Int J Radiat Oncol Biol Phys (2010) 0.94
Bone marrow transplantation for severe aplastic anemia secondary to temozolomide. J Neurooncol (2008) 0.92
Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. J Neurooncol (2013) 0.91
"Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis? Neuroradiology (2014) 0.91
Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition. Pediatr Blood Cancer (2010) 0.90
Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort. Pediatr Blood Cancer (2013) 0.90
Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imaging. Int J Radiat Oncol Biol Phys (2011) 0.90
Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol (2010) 0.89
Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. J Neurosurg Pediatr (2008) 0.88
Pediatric low-grade gliomas and the need for new options for therapy: Why and how? Cancer Biol Ther (2009) 0.88
Evaluation of the biodistribution of 11C-methionine in children and young adults. J Nucl Med (2013) 0.88
Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma. Stem Cells Transl Med (2012) 0.87
Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma. Neuro Oncol (2012) 0.87
The catheter-driven MRI scanner: a new approach to intravascular catheter tracking and imaging-parameter adjustment for interventional MRI. AJR Am J Roentgenol (2004) 0.87
M1 Medulloblastoma: high risk at any age. J Neurooncol (2008) 0.87
Elevated T2-values in MRI of stroke patients shortly after symptom onset do not predict irreversible tissue infarction. Brain (2012) 0.87
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors. Childs Nerv Syst (2012) 0.86
Simultaneous field and R2 mapping to quantify liver iron content using autoregressive moving average modeling. J Magn Reson Imaging (2011) 0.86
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging (2008) 0.85
Image-guided and -monitored renal artery stenting using only MRI. J Magn Reson Imaging (2006) 0.85